Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biogen Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BIIB
Nasdaq
2834
https://www.biogen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biogen Inc
Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past year
- Apr 25th, 2024 2:52 pm
For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
- Apr 25th, 2024 11:00 am
Q1 2024 Biogen Inc Earnings Call
- Apr 25th, 2024 5:23 am
Why Biogen Stock Leaped Nearly 5% Higher Today
- Apr 24th, 2024 10:18 pm
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations
- Apr 24th, 2024 8:19 pm
Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
- Apr 24th, 2024 6:12 pm
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
- Apr 24th, 2024 4:57 pm
Biogen (BIIB) Q1 2024 Earnings Call Transcript
- Apr 24th, 2024 4:45 pm
Biogen: Don’t expect any big acquisitions this year
- Apr 24th, 2024 4:28 pm
Biogen Stock Rises After Earnings, Jump in Sales of Alzheimer’s Drug
- Apr 24th, 2024 3:08 pm
Biogen stock rises on Q1 results, Alzheimer's drug sales
- Apr 24th, 2024 2:28 pm
Biogen Affirms Guidance After Mixed First Quarter
- Apr 24th, 2024 2:05 pm
Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
- Apr 24th, 2024 1:39 pm
Biogen Beats Estimates as Alzheimer’s Drug Gains Traction
- Apr 24th, 2024 1:34 pm
Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- Apr 24th, 2024 1:30 pm
Biogen Inc (BIIB) Q1 2024 Earnings: Mixed Results Amidst Strategic Growth Efforts
- Apr 24th, 2024 12:32 pm
Biogen sees ‘encouraging’ trends for postpartum depression drug
- Apr 24th, 2024 12:16 pm
Biogen to invest more in launch of Alzheimer’s drug Leqembi
- Apr 24th, 2024 12:09 pm
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start
- Apr 24th, 2024 10:48 am
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
- Apr 24th, 2024 10:45 am
Scroll